Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 6 studies | 25% ± 10% | |
epithelial cell | 5 studies | 22% ± 10% | |
hepatocyte | 5 studies | 45% ± 12% | |
astrocyte | 5 studies | 25% ± 7% | |
glutamatergic neuron | 4 studies | 31% ± 12% | |
microglial cell | 4 studies | 21% ± 6% | |
GABAergic neuron | 3 studies | 35% ± 9% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 7% | |
dendritic cell | 3 studies | 21% ± 2% | |
neuron | 3 studies | 22% ± 7% | |
oligodendrocyte | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2193.04 | 245 / 245 | 100% | 59.11 | 502 / 502 |
brain | 100% | 1561.99 | 2641 / 2642 | 100% | 42.36 | 705 / 705 |
esophagus | 100% | 1549.94 | 1444 / 1445 | 100% | 31.26 | 183 / 183 |
breast | 100% | 1622.41 | 459 / 459 | 100% | 56.56 | 1116 / 1118 |
liver | 100% | 9481.83 | 226 / 226 | 99% | 72.75 | 403 / 406 |
pancreas | 100% | 1910.38 | 328 / 328 | 99% | 19.48 | 176 / 178 |
intestine | 100% | 1571.83 | 966 / 966 | 99% | 23.08 | 520 / 527 |
ovary | 100% | 2331.94 | 180 / 180 | 99% | 28.81 | 424 / 430 |
stomach | 100% | 1816.08 | 359 / 359 | 98% | 22.85 | 281 / 286 |
uterus | 100% | 1574.05 | 170 / 170 | 98% | 28.93 | 450 / 459 |
lung | 99% | 1212.57 | 570 / 578 | 99% | 28.04 | 1148 / 1155 |
bladder | 100% | 1549.86 | 21 / 21 | 98% | 28.13 | 493 / 504 |
thymus | 100% | 1955.02 | 653 / 653 | 98% | 20.26 | 590 / 605 |
kidney | 100% | 3222.45 | 89 / 89 | 97% | 38.66 | 871 / 901 |
skin | 100% | 1356.10 | 1803 / 1809 | 95% | 23.42 | 449 / 472 |
adrenal gland | 100% | 2071.54 | 258 / 258 | 80% | 11.13 | 184 / 230 |
adipose | 100% | 1617.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2427.70 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1692.02 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.14 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.18 | 1 / 1 |
blood vessel | 100% | 1480.57 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 1394.04 | 817 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 2203.50 | 874 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 17.63 | 72 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 30.11 | 26 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0006096 | Biological process | glycolytic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0030976 | Molecular function | thiamine pyrophosphate binding |
GO_0160166 | Molecular function | 2-oxoadipate dehydrogenase activity |
GO_0004591 | Molecular function | oxoglutarate dehydrogenase (succinyl-transferring) activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DHTKD1 |
Protein name | 2-oxoadipate dehydrogenase complex component E1 (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial) Dehydrogenase E1 and transketolase domain containing 1 2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial) |
Synonyms | KIAA1630 |
Description | FUNCTION: 2-oxoadipate dehydrogenase (E1a) component of the 2-oxoadipate dehydrogenase complex (OADHC) . Participates in the first step, rate limiting for the overall conversion of 2-oxoadipate (alpha-ketoadipate) to glutaryl-CoA and CO(2) catalyzed by the whole OADHC . Catalyzes the irreversible decarboxylation of 2-oxoadipate via the thiamine diphosphate (ThDP) cofactor and subsequent transfer of the decarboxylated acyl intermediate on an oxidized dihydrolipoyl group that is covalently amidated to the E2 enzyme (dihydrolipoyllysine-residue succinyltransferase or DLST) (Probable) . Can catalyze the decarboxylation of 2-oxoglutarate in vitro, but at a much lower rate than 2-oxoadipate . Responsible for the last step of L-lysine, L-hydroxylysine and L-tryptophan catabolism with the common product being 2-oxoadipate (Probable). . |
Accessions | H7C1J3 ENST00000415935.1 C9JWN1 ENST00000448829.1 ENST00000263035.9 ENST00000437298.1 Q96HY7 H7C149 |